Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Lancet Neurology

• Publication date

  2015-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S1474-4422(14)70251-0PMID 25575710PMCID PMC4493167
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Risk‐stratification management of febrile neutropenia in pediatric hematology‐oncology patients: Results of a French nationwide survey

  2016cited by this paper
• Evidence of specific cognitive deficits in patients with chronic low back pain under long-term substitution treatment of opioids.

  2014cited by this paper
• Adherence of French GPs to Chronic Neuropathic Pain Clinical Guidelines: Results of a Cross-Sectional, Randomized, “e” Case-Vignette Survey

  2014cited by this paper
• Cannabis Use Is Quantitatively Associated with Nucleus Accumbens and Amygdala Abnormalities in Young Adult Recreational Users

  2014cited by this paper
• Correlations between prescription opioid analgesic dispensing levels and related mortality and morbidity in Ontario, Canada, 2005-2011.

  2014cited by this paper
• Opioid Prescribing: A Systematic Review and Critical Appraisal of Guidelines for Chronic Pain

  2014cited by this paper
• Effect of variability in the 7‐day baseline pain diary on the assay sensitivity of neuropathic pain randomized clinical trials: An ACTTION study

  2014cited by this paper
• Opioid-Induced Endocrinopathy in Cancer Patients: An Underestimated Clinical Problem

  2014cited by this paper
• Neuropathic pain phenotyping as a predictor of treatment response in painful diabetic neuropathy: Data from the randomized, double‐blind, COMBO‐DN study

  2014cited by this paper
• The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: A randomised, double‐blind, placebo‐controlled phenotype‐stratified study

  2014cited by this paper
• Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline.

  2014cited by this paper
• Randomised Controlled Trials May Underestimate Drug Effects: Balanced Placebo Trial Design

  2014cited by this paper
• Sensory profiles of patients with neuropathic pain based on the neuropathic pain symptoms and signs

  2014cited by this paper
• Prescription opioid abuse in the UK.

  2013cited by this paper
• Interventional management of neuropathic pain: NeuPSIG recommendations

  2013cited by this paper
• Association between cannabis use, psychosis, and schizotypal personality disorder: findings from the National Epidemiologic Survey on Alcohol and Related Conditions.

  2013cited by this paper
• Neuropathic pain in the community: More under-treated than refractory?

  2013cited by this paper
• Neuropathic pain in children

  2013cited by this paper
• Drugs for neuropathic pain

  2013cited by this paper
• The Role of Opioid Prescription in Incident Opioid Abuse and Dependence Among Individuals With Chronic Noncancer Pain: The Role of Opioid Prescription

  2013cited by this paper
• Combination pharmacotherapy for management of chronic pain: from bench to bedside.

  2013cited by this paper
• The burden associated with neuropathic pain in Western Europe

  2013cited by this paper
• Trends and Regional Variation in Opioid Overdose Mortality Among Veterans Health Administration Patients, Fiscal Year 2001 to 2009

  2013cited by this paper
• Assay sensitivity and study features in neuropathic pain trials

  2013cited by this paper
• Duloxetine and pregabalin: High‐dose monotherapy or their combination? The “COMBO‐DN study” – a multinational, randomized, double‐blind, parallel‐group study in patients with diabetic peripheral neuropathic pain

  2013cited by this paper
• Is treatment of postherpetic neuralgia in the community consistent with evidence‐based recommendations?

  2012cited by this paper
• COMBINATION PHARMACOTHERAPY FOR THE TREATMENT OF NEUROPATHIC PAIN IN ADULTS

  2012cited by this paper
• American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults

  2012cited by this paper
• Deconstructing the neuropathic pain phenotype to reveal neural mechanisms.

  2012cited by this paper
• Subgrouping of patients with neuropathic pain according to pain-related sensory abnormalities: a first step to a stratified treatment approach.

  2012cited by this paper
• American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults

  2012cited by this paper
• Randomized control trial of topical clonidine for treatment of painful diabetic neuropathy

  2012cited by this paper
• Placebo response changes depending on the neuropathic pain syndrome: results of a systematic review and meta-analysis.

  2012cited by this paper
• Sensory Symptom Profiles and Co-Morbidities in Painful Radiculopathy

  2011cited by this paper
• NeuPSIG guidelines on neuropathic pain assessment

  2011cited by this paper
• Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study

  2011cited by this paper
• The specific disease burden of neuropathic pain: Results of a French nationwide survey

  2011cited by this paper
• GRADE guidelines: 3. Rating the quality of evidence.

  2011cited by this paper
• Evidence-based guideline: Treatment of painful diabetic neuropathy

  2011cited by this paper
• Assessing symptom profiles in neuropathic pain clinical trials: Can it improve outcome?

  2011cited by this paper
• Cannabis and the increased incidence and persistence of psychosis

  2011cited by this paper
• Evidence-based guideline: Treatment of painful diabetic neuropathy: Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation

  2011cited by this paper
• Sensation

  2011cited by this paper
• Single dose oral analgesics for acute postoperative pain in adults.

  2011cited by this paper
• Opioids for chronic noncancer pain: a new Canadian practice guideline

  2010cited by this paper
• Publication Bias in Reports of Animal Stroke Studies Leads to Major Overstatement of Efficacy

  2010cited by this paper
• AGREE II: advancing guideline development, reporting and evaluation in health care

  2010cited by this paper
• Diabetic Neuropathy

  2010cited by this paper
• Pharmacological management of neuropathic pain in non-specialist settings: summary of NICE guidance

  2010cited by this paper
• [Neuropathic pain in children].

  2010cited by this paper
• The burden of neuropathic pain: A systematic review and meta‐analysis of health utilities

  2010cited by this paper
• The evidence for pharmacological treatment of neuropathic pain

  2010cited by this paper
• EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision

  2010cited by this paper
• Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment.

  2010cited by this paper
• AGREE II: advancing guideline development, reporting, and evaluation in health care.

  2010cited by this paper
• Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement

  2009cited by this paper
• Comment on AAN‐EFNS guidelines on trigeminal neuralgia management

  2009cited by this paper
• Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

  2009cited by this paper
• High-potency cannabis and the risk of psychosis

  2009cited by this paper
• GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

  2008cited by this paper
• Prevalence of chronic pain with neuropathic characteristics in the general population

  2008cited by this paper
• Neuropathic pain: Are there distinct subtypes depending on the aetiology or anatomical lesion?

  2008cited by this paper
• Neuropathic pain

  2008cited by this paper
• AAN‐EFNS guidelines on trigeminal neuralgia management

  2008cited by this paper
• The treatment of neuropathic pain: from hubris to humility.

  2007cited by this paper
• Pharmacologic management of neuropathic pain: Evidence‐based recommendations

  2007cited by this paper
• Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society.

  2007cited by this paper
• EFNS guidelines on pharmacological treatment of neuropathic pain

  2006cited by this paper
• Cannabis as a risk factor for psychosis: systematic review

  2005cited by this paper
• Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the quality standards subcommittee of the American Academy of Neurology

  2005cited by this paper
• Practice Parameter: Treatment of postherpetic neuralgia: An evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology*

  2004cited by this paper
• Cyclic antidepressants and the risk of sudden cardiac death

  2004cited by this paper
• Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations.

  2003cited by this paper
• Publication bias in meta-analysis: its causes and consequences.

  2000cited by this paper
• Trim and Fill: A Simple Funnel‐Plot–Based Method of Testing and Adjusting for Publication Bias in Meta‐Analysis

  2000cited by this paper
• Topical capsaicin in humans: parallel loss of epidermal nerve fibers and pain sensation.

  1999cited by this paper
• Bias in meta-analysis detected by a simple, graphical test

  1997cited by this paper
• Assessing the quality of reports of randomized clinical trials: is blinding necessary?

  1996cited by this paper
• Meta-analysis in clinical research.

  1987cited by this paper
• Summing Up: The Science of Reviewing Research Harvard University Press: Cambridge, MA, 1984, xiii+191 pp

  1984cited by this paper
• GrADE: an emerging consensus on rating quality of evidence and strength of recommendations

  year unknowncited by this paper

• Mendelian randomization studies on the causal relationship between insomnia and disease.

  2026cites this paper
• The bridging role of gut microbiota-derived metabolites in neuropathic pain comorbid with anxiety.

  2026cites this paper
• Effectiveness of Pulsed Electromagnetic Field Therapy on Neuropathic Pain: A Systematic Review and Meta-Analysis.

  2026cites this paper
• Prevalence and Associated Factors of Postoperative Neuropathic Pain

  2026cites this paper
• Inclusion of “palliative care pharmacology” as a new chapter in the pharmacology textbook for medical undergraduate students: A strength, weakness, opportunity, and threat analysis

  2026cites this paper
• A review of preclinical research on mechanically gated ion channels as therapeutic targets in neuropathic pain

  2026cites this paper
• Dry Needling as Potent Treatment Modality for Post-herpetic Neuralgia

  2026cites this paper
• Tumorassoziierte Schmerzen effektiv behandeln – was ist möglich und sinnvoll?

  2026cites this paper
• Diagnosis, Pathology, and Management of Pain in the Ischemic Hand: A Comprehensive Review.

  2026cites this paper
• Mécanismes d’action de la neurostimulation médullaire dans la douleur neuropathique: entre hypothèses précliniques et réalités cliniques

  2026cites this paper
• Lucerastat, an oral therapy for Fabry disease: results from a pivotal randomized phase 3 study and its open-label extension

  2026cites this paper
• Targeting pain with deep brain stimulation: Insights into the thalamus and associated structures

  2026cites this paper
• Central effects of short-term spinal cord stimulation in postherpetic neuralgia: a longitudinal fMRI and DTI study

  2026cites this paper
• Differential microglial dynamics and neuroinflammation underlying neuropathic pain in the central nervous system: comparative insights from spinal cord injury and compressive myelopathy models

  2026cites this paper
• Development of 6-methyl-4,5-dihydropyrazolo[3,4-d]pyrimidin-4-one derivatives as lead sigma-1 receptor inhibitor: synthesis and biological evaluation via MSI.

  2026cites this paper
• Characterization of Novel Sigma Receptor Ligands Derived from Multicomponent Reactions as Efficacious Treatments for Neuropathic Pain

  2026cites this paper
• Risk of fractures among patients with postherpetic neuralgia receiving pregabalin: real-world evidence from Taiwan.

  2026cites this paper
• Potential Roles of Metabolomic Alterations in Neuropathic Pain: Evidence from In Vivo to Clinical Studies.

  2026cites this paper
• A reversible allosteric inhibitor of GlyT2 for neuropathic pain without on-target side effects.

  2026cites this paper
• The relationship between pain level and satisfaction following lumbar spinal stenosis surgery and psychiatric medication use

  2026cites this paper
• Pain Management in Italian Elite Athletes: Trends in the Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Glucocorticoids, and Narcotics in Anti-Doping Reports (2013-2023).

  2026cites this paper
• Photobiomodulation Therapy in the Management of Orofacial Neuropathic Pain—WALT Position Paper 2026

  2026influential citation
• The Use of Botulinum Toxin Injections in Peripheral Neuropathic Pain: A Systematic Review of Efficacy and Safety Outcomes

  2026cites this paper
• Receptor Tyrosine Kinases in Alzheimer's Disease: Mechanistic Insights and Therapeutic Implications.

  2026cites this paper
• Resolution of post-traumatic lumbar disc herniation following diamagnetic therapy: a case report.

  2026cites this paper
• Bee venom or melittin acupoint injection controls neuropathic pain in rats through the modulation of neuroinflammatory factors.

  2026cites this paper
• Effects of spinal cord stimulation on pain, physical activity, and self-efficacy among patients with neuropathic pain.

  2026cites this paper
• Mechanism of human umbilical cord mesenchymal stem cell-derived exosomes in alleviating neuropathic pain in CCI rats

  2026cites this paper
• iRhom2 deletion protects against diabetic neuropathy by suppressing neuroinflammation.

  2026cites this paper
• Transient silencing of spinal nociceptive neurons leads to a long-term reduction in joint pain mediated by recruitment of opioid activity

  2026cites this paper
• Prise en charge initiale d’un patient traumatisé du rachis

  2026cites this paper
• Mismatch between intact electrical excitability and lost heat pain in diabetic neuropathy.

  2026cites this paper
• Contribution of proneurotrophin-3 to nerve trauma-induced neuropathic pain through promoting TrkC-mediated increase of CCL2 in primary sensory neurons.

  2026cites this paper
• Biomarkers and Breakdowns: Neuroinflammatory Drivers Linking Sleep Disorders and Chronic Pain

  2026cites this paper
• Chronic Pain in Multiple Sclerosis: Mechanisms, Clinical Characteristics and Treatment Strategies

  2026influential citation
• Cannabis-based medicines for chronic neuropathic pain in adults.

  2026cites this paper
• Patients with recent-onset systemic lupus erythematosus use more antidepressant medication than matched controls: A case–control study

  2026cites this paper
• A roadmap for transcranial direct current stimulation for chronic pain.

  2026cites this paper
• Neuralgia-Inducing Cavitational Osteonecrosis (NICO): A Scoping Review of a Controversial Concept in Orofacial Pain

  2026cites this paper
• Effects of Mental Health on 30-Day Postoperative Outcomes Following Peripheral Nerve Repair.

  2026cites this paper
• Cooling the burn: EMLA alone vs. paravertebral block plus EMLA for improving tolerability of 8% capsaicin patch application in thoracic postherpetic neuralgia-a retrospective cohort study.

  2026cites this paper
• Actualización en Neuropatías Craneofaciales y Periféricas: De la Taxonomía CIE-11 a la Medicina de Precisión

  2026cites this paper
• A Narrative Review of Perioperative Peripheral Nerve Injuries After Major Surgery: Clinical Recognition, Electrodiagnostic Evaluation, and Rehabilitation Implications

  2026cites this paper
• TRPV1 Receptor Modulators: Emerging Therapies for Neuropathic, Osteoarthritic, and Perioperative Pain.

  2026cites this paper
• Safety and Efficacy of Magnetic Peripheral Nerve Stimulation for Treating Painful Diabetic Neuropathy.

  2025cites this paper
• Diabetic neuropathy: cutting-edge research and future directions

  2025influential citation
• Neuro-Nutritional Approach to Neuropathic Pain Management: A Critical Review

  2025cites this paper
• Neuropathic pain: which treatment for which patient?

  2025cites this paper
• Potential Anti-inflammatory Properties of Corydalis rhizoma for Co-Treatment of Neuropathic Pain and Major Depressive Disorder: Network Pharmacology with Molecular Docking and Molecular Dynamics Simulation Approaches.

  2025cites this paper
• Long‐term efficacy of 10 kHz spinal cord stimulation in managing painful diabetic neuropathy: A post‐study survey

  2025cites this paper
• Effects of stellate ganglion block on inflammation and autophagy of spinal cord neurons in rats with neuropathic pain after spinal cord injury.

  2025cites this paper
• Antidepressant non-refill as a Proxy Measure for Medication Acceptability in Electronic Health Records.

  2025cites this paper
• Analgesic Mechanism of Emodin in Neuropathic Pain Through Inhibiting P2X4 Purinoceptor Signaling

  2025cites this paper
• Multimodal Therapies for the Treatment of Neuropathic Pain: The Role of Lidocaine Patches in Combination Therapy: A Narrative Review

  2025cites this paper
• Efficacy and safety of capsaicin 8% patches: The experience of a rheumatology department

  2025cites this paper
• High Concentrations of the Antidepressant Amitriptyline Activate and Desensitize the Capsaicin Receptor TRPV1

  2025cites this paper
• A sensory-motor-sensory circuit underlies antinociception ignited by primary motor cortex in mice.

  2025cites this paper
• Pharmacotherapy and non-invasive neuromodulation for neuropathic pain: a systematic review and meta-analysis.

  2025cites this paper
• Immune Dysregulation in Depression and Anxiety: A Review of the Immune Response in Disease and Treatment

  2025cites this paper
• Cannabinoids in neuropathic pain treatment: pharmacological insights and clinical outcomes from recent trials

  2025cites this paper
• A reversible allosteric inhibitor of GlyT2 alleviates neuropathic pain without on-target side effects

  2025cites this paper
• Neuropathic pain: proposal of a mechanism-based treatment

  2025cites this paper
• Pain, quality of life, and function in chronic intractable leg pain were substantially improved with 10kHz spinal cord stimulation in a multicentre European study

  2025cites this paper
• Neuropathic Pain: A Comprehensive Bibliometric Analysis of Research Trends, Contributions, and Future Directions

  2025cites this paper
• Neural networks involved in painful diabetic neuropathy: A systematic review

  2025cites this paper
• Management of post-arthroplasty pain: a narrative review of emerging interventional treatments.

  2025cites this paper
• Pharmacological and interventional treatment of phantom pain

  2025cites this paper
• Bidirectional Modulation of Somatostatin-expressing Interneurons in the Basolateral Amygdala Reduces Neuropathic Pain Perception in Mice

  2025cites this paper
• The Effectiveness of Amitriptyline and Gabapentin in Treating Pomeranians with Chiari-like Malformation and/or Syringomyelia

  2025cites this paper
• Serum Biomarkers and Their Clinical Correlates in Traumatic Trigeminal Neuropathy: A Pilot Study

  2025cites this paper
• Focus on P2X7R in microglia: its mechanism of action and therapeutic prospects in various neuropathic pain models

  2025influential citation
• Expansion of OSMR expression and signaling in the human dorsal root ganglion links OSM to neuropathic pain

  2025cites this paper
• Identifying predictors of neuropathic pain medication prescribing, adherence, and discontinuation: a systematic review and meta-analysis

  2025cites this paper
• Exploring the Potential of Dietary Supplements to Alleviate Pain Due to Long COVID

  2025cites this paper
• cGMP-dependent protein kinase I in the dorsal hippocampus protects against synaptic plasticity and cognitive deficit induced by chronic pain.

  2025cites this paper
• Phenyl-benzyl-ureas with pyridazinone motif: Potent soluble epoxide hydrolase inhibitors with enhanced pharmacokinetics and efficacy in a paclitaxel-induced neuropathic pain model.

  2025cites this paper
• A computational genetic- and transcriptomics-based study nominates drug repurposing candidates for the treatment of chronic pain

  2025cites this paper
• Elucidation of Dexmedetomidine‐Induced Analgesic Tolerance Mechanisms in Neuropathic Pain With Modulation of SGK1 , NR2A , and NR2B Expression via the Spinal SGK1 / NF ‐ κB Signalling Pathway

  2025cites this paper
• The presence and prognosis of nerve pathology following whiplash injury: a prospective cohort study

  2025cites this paper
• Congrès de la SFETD, Lille, novembre 2024. Première partie

  2025cites this paper
• Managing a Burning Face: Clinical Manifestations and Therapeutic Approaches for Neurogenic Rosacea

  2025cites this paper
• Emerging role of macrophages in neuropathic pain

  2025cites this paper
• The angiotensin II type 2 receptor antagonists, PD123,319 ((S-( +)-1-[(4-(dimethylamino)-3-methylphenyl)methyl]-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid), EMA300 (5-(2,2-diphenylacetyl)-4-[(4-methoxy-3-methylphenyl)methyl]-1,4,6,7-tetrahydroimidazo[4,5-c]pyri

  2025influential citation
• Chronic orofacial pain and pharmacological management-a clinical guide.

  2025cites this paper
• Diroximel Fumarate Acts Through Nrf2 to Attenuate Methylglyoxal-Induced Nociception in Mice and Decrease ISR Activation in DRG Neurons

  2025cites this paper
• Allodynia: A Review Article

  2025cites this paper
• Rodent Models of Diabetic Neuropathy, Role of Calcium Homeostasis in Pain and KB-R7943 as a Potential Therapeutic

  2025cites this paper
• Drug Usability Survey (DUS) of Gabapentinoid and Its Combinations Among Indian Patients With Neuropathic Pain: Results From a Real-World, Multicenter, Retrospective Survey at Neurology Clinics

  2025cites this paper
• Foundation-Model-Boosted Multimodal Learning for fMRI-based Neuropathic Pain Drug Response Prediction

  2025cites this paper
• Botulinum toxin effects on biochemical biomarkers related to inflammation-associated head and neck chronic conditions: a systematic review of clinical research

  2025cites this paper
• Comparative analysis of the therapeutic effects of pregabalin, gabapentin, and duloxetine in diabetic peripheral neuropathy: A retrospective study.

  2025cites this paper
• Assessing the Efficacy of Botulinum Toxin in Treating Neuropathic Pain: A Report of Two Cases

  2025influential citation
• Assess the Efficacy of Epsom Salt Foot Bath in Preventing or Delaying the Onset of Chemotherapy-induced Neurological Manifestations in Cancer Patients

  2025cites this paper
• Non-Pharmacological Interventions Addressing Chronic Pain in People Living with HIV

  2025cites this paper
• Defective PINK1-dependent mitophagy is involved in high glucose-induced neurotoxicity.

  2025cites this paper
• VARICELLA AND HERPES ZOSTER (NAMLA MINTẠ QIYYA) UNANI PERSPECTIVES: A HOLISTIC APPROACH TO MANAGEMENT

  2025cites this paper
• Chronic pelvic pain and botulinum toxin.

  2025cites this paper
• Best Practices, Resources and Innovations: A Mechanistic Review of Nausea and Vomiting Management Options in Cirrhosis

  2025cites this paper
• Analgesic efficacy of non-invasive neuromodulation techniques in chronic cancer pain: a systematic review

  2025cites this paper
• Application of a Nociceptive Test Battery to Assess Potential Synergy between Two Analgesics in Healthy Subjects

  2025cites this paper